Education
About Us
Working with TipRanks
Follow Us
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 152.43K | $ 969.78K | $ 355.80K | $ 483.05K | $ 701.72K |
| Gross Profit | $ -149.61K | $ 683.37K | $ 350.71K | $ 464.33K | $ 681.58K |
| Operating Income | $ -8.22M | $ -15.11M | $ -11.35M | $ -8.51M | $ -3.46M |
| EBITDA | $ -8.13M | $ -15.20M | $ -10.97M | $ -10.37M | $ -3.47M |
| Net Income | $ -10.52M | $ -16.31M | $ -12.04M | $ -10.59M | $ -3.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 139.47K | $ 161.06K | $ 5.94M | $ 4.27M | $ 144.29K |
| Total Assets | $ 14.49M | $ 9.86M | $ 13.70M | $ 11.61M | $ 6.93M |
| Total Debt | $ 2.28M | $ 3.05M | $ 3.11M | $ 6.48M | $ 4.58M |
| Net Debt | $ 2.22M | $ 2.97M | $ -2.72M | $ 2.21M | $ 4.44M |
| Total Liabilities | $ 6.36M | $ 6.24M | $ 4.83M | $ 8.94M | $ 7.05M |
| Stockholders' Equity | $ 8.39M | $ 3.10M | $ 8.84M | $ 3.44M | $ -150.96K |
| Cash Flow | |||||
| Free Cash Flow | $ -4.26M | $ -7.52M | $ -7.62M | $ -4.56M | $ -3.13M |
| Operating Cash Flow | $ -4.24M | $ -7.40M | $ -7.60M | $ -4.56M | $ -3.13M |
| Investing Cash Flow | $ -360.19K | $ -1.72M | $ -805.97K | $ -225.43K | $ -35.30K |
| Financing Cash Flow | $ 3.92M | $ 4.01M | $ 10.00M | $ 9.57M | $ 3.09M |